Not yet recruitingInterventionalNot ApplicableLast updated Aug 10, 2026

OCM™ Treatment With Routine Care in Venous Leg Ulcers Compared to Routine Care Treatment Alone.

A Multicenter, Randomized, Controlled, Open Label Study Comparing Treatment With OCM™️ Plus Compression and Routine Care, to Compression and Routine Care Alone for Venous Leg Ulcers

Overview

ClinicalTrials.gov ID: NCT07754526
Lead Sponsor: Omeza, LLCINDUSTRY
Brief Summary: The purpose of the study is to assess the use of OCM™ for the treatment of vascular leg ulcers (VLUs). The study seeks to evaluate the results of treating VLUs with OCM™ plus routine care and compression for complete wound healing; ability of the patient to return to previous function and resume normal activity, and reduction in the size of the wound. The results will be compared to patients who undergo routine care and compression without OCM™.

Status

Overall Status: Not yet recruiting
Start Date: Aug 2026Estimated
Primary Completion Date: Sep 2027Estimated
Completion Date: Dec 2028Estimated

Study Record Dates

First Submitted: Jul 23, 2026
First Submitted that Met QC Criteria: Aug 6, 2026
First Posted: Aug 10, 2026Actual
Last Update Submitted that Met QC Criteria: Aug 6, 2026
Last Update Posted: Aug 10, 2026Actual
Last Verified: Aug 2026

NCT05291169Completed

Omeza Combination Therapy With Standard of Care to Standard of Care Alone for Chronic Venous Leg Ulcers

NCT04198441Unknown status

The Omeza Protocol for Chronic Ulcers

NCT07161830Recruiting

Evaluating the Efficacy of OCM™ (Omeza® Complete Matrix) in the Treatment of Diabetic Foot Ulcers

NCT05417425Completed

Omeza Products in Combination With Standard of Care for the Treatment of Diabetic Foot Ulcers

NCT05921292Completed

Omeza Combination Therapy for the Management and Treatment of Chronic Cutaneous Wounds/Ulcers of Multiple Etiologies

NCT04441957Unknown status

MechanO-Chemical Ablation Versus CompreSSion